Multidisciplinary Association for Psychedelic Studies

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a non-profit research and educational organization based in the UK, dedicated to the study and promotion of psychedelic substances for therapeutic purposes. Founded in 1986, MAPS has been at the forefront of advocating for the medical use of psychedelics, aiming to develop them into legal prescription medicines.

MAPS conducts rigorous scientific research to explore the potential benefits of psychedelics in treating various mental health conditions, including PTSD, depression, and anxiety. The organization collaborates with leading researchers, clinicians, and institutions worldwide to ensure that their studies meet the highest ethical and scientific standards.

In addition to research, MAPS is committed to educating the public and healthcare professionals about the safe and effective use of psychedelics. They provide resources, training, and support for therapists and practitioners interested in integrating these substances into their practice.

MAPS also advocates for policy changes to facilitate the legal use of psychedelics in therapy, working closely with regulatory bodies and lawmakers. Their vision is to create a world where psychedelics are accepted as valuable tools for healing and personal growth.

Through its innovative approach, MAPS aims to destigmatize psychedelics and promote a deeper understanding of their potential benefits. The organization believes in a multidisciplinary approach, combining insights from psychology, neuroscience, and spirituality to foster a holistic understanding of human consciousness.

As a leader in the field, MAPS continues to push the boundaries of what is possible in psychedelic research, striving to unlock the therapeutic potential of these substances for future generations.